Antiparasitic Drugs Market Set To Grow From $27.17 Billion In 2026 To $36.13 Billion By 2030 At A CAGR Of 7.4%
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Antiparasitic Drugs Market Growth Potential: How Will Market Size Change Through 2030?
The antiparasitic drugs market has experienced robust expansion in recent years. It is projected to increase from $25.58 billion in 2025 to $27.18 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.2%. Several factors drove this growth during the historical period, including a rising incidence of parasitic infections, restricted availability of modern antiparasitic treatments in developing areas, a historical dependence on monotherapy agents, growing demand for veterinary services, and insufficient awareness regarding preventive strategies.
The market for antiparasitic drugs is projected to experience robust expansion in the coming years, reaching a value of $36.13 billion by 2030, with a compound annual growth rate (CAGR) of 7.4%. This anticipated growth during the forecast period is driven by factors such as the increasing adoption of combination therapies, progress in precision medicine aimed at treating parasitic infections, a heightened focus on animal health and livestock protection, the expansion of emerging markets, and the creation of innovative drug delivery systems. Key developments shaping this period include a rising prevalence of parasitic diseases, the development of combined antiparasitic treatments, broader use in animal healthcare, a growing preference for oral and injectable administration methods, and the introduction of new antiparasitic agents.
Download A Free Sample Report For Comprehensive Market Insights:
Antiparasitic Drugs Market Opportunity Drivers: What Is Creating New Revenue Potential?
The growth of the antiparasitic drugs market is set to accelerate in the future, driven largely by the rising prevalence of vector-borne diseases. These illnesses, which include malaria, dengue, and yellow fever, are spread to humans and animals through the bites of arthropods such as mosquitoes, ticks, and flies. Antiparasitic medications are critical in controlling the transmission of these diseases, as they directly target and eliminate the parasites involved. Common drugs like chloroquine, doxycycline, and atovaquone-proguanil are frequently prescribed to treat malaria. A report from the Centers for Disease Control and Prevention, a U.S. federal agency, noted that from January to June 2024, over 9.7 million dengue cases were recorded in the Americas—more than doubling the 4.6 million cases seen throughout 2023. In the United States alone, Puerto Rico reported 1,498 cases, while 745 infections were found among returning travelers. Consequently, the growing incidence of vector-borne diseases is fueling expansion in the antiparasitic drugs market.
Antiparasitic Drugs Market Segmentation: How Is The Market Structured Across Key Categories?
The antiparasitic drugs market covered in this report is segmented –
1) By Product Type: Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products
2) By Treatment: Avermectins, Bezimidazoles, Pyrimidines, Imidazolesthiazoles
3) By Route of Administration: Oral, Injectable, Topical
4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Anthelmintics: Benzimidazoles, Ivermectin, Pyrantel Pamoate, Praziquantel
2) By Antiprotozoals: Metronidazole, Tinidazole, Nitazoxanide, Pentamidine
3) By Ectoparasiticides: Permethrin, Malathion, Fipronil
4) By Other Products: Combination Antiparasitic Drugs, Novel Antiparasitic Agents
Antiparasitic Drugs Market Innovation Trends Driving Future Development
Major players in the antiparasitic drugs market are concentrating on creating new products, particularly chewable veterinary options, to make administration easier and boost pet compliance. Chewable veterinary products consist of flavored tablets or treats that are simple to give and are designed to deliver medication to animals. These formulations improve compliance by making the treatment process more appealing and less stressful. As an example, in April 2024, C.H. Boehringer Sohn AG and Co. KG, a pharmaceutical company based in Germany, introduced NexGard Spectra for comprehensive parasite management. NexGard SPECTRA is a soft, savory chew that offers full coverage against internal and external parasites in dogs, targeting fleas, ticks, heartworms, and a range of intestinal worms with just one monthly dose. It shows fast effectiveness, killing fleas within four hours after administration and attaining over 99% efficacy against multiple parasites soon after.
Antiparasitic Drugs Market Competitive Landscape And Leading Companies
Major companies operating in the antiparasitic drugs market are Pfizer Inc., Johnson & Johnson, Cadila Pharmaceuticals, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim Group, Zoetis Inc., Eisai Co. Ltd., Dr. Reddy’s Laboratories, Intas Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ceva Santé Animale S.A., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Mankind Pharma, Bimeda Inc., Indoco Remedies Ltd., ECO Animal Health, Lincoln Pharmaceuticals Ltd., Laboratorios Calier
Access The Complete Antiparasitic Drugs Market Report:
Antiparasitic Drugs Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the antiparasitic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antiparasitic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
